Prime Highlights
- First close exceeds one-third of ₹1,700 crore target.
- Fund III makes first investment in Lifesigns.
Key Facts
- HealthQuad focuses on early-growth healthcare startups.
- Fund backs HealthTech, MedTech and Bio/Pharma Tech firms.
Background
HealthQuad, the early-growth healthcare investment platform backed by Quadria Group, has achieved the first close of its third fund with commitments of ₹550 crore. The amount represents more than one-third of the fund’s target size of ₹1,700 crore and includes support from existing limited partners as well as new investors comprising fund of funds, institutions and family offices from India and overseas.
The fund has already invested for the first time in Lifesigns, a platform for remote patient monitoring driven by artificial intelligence. HealthQuad is also evaluating several other investment opportunities as it begins deploying capital under Fund III.
Fund III, which is managed by HealthQuad Advisors Private Limited, is a continuation of the company’s previous healthcare-focused funds that supported over eighteen businesses in the fields of digital health, healthcare technology, and diagnostics. Several portfolio firms have grown into leading players in their respective categories.
The new fund will focus on early-growth companies operating in HealthTech, MedTech, Bio/Pharma Tech and innovative healthcare delivery models. HealthQuad believes these segments are expanding rapidly and are expected to account for a significant share of India’s healthcare market by the end of the decade.
According to the company, India still faces significant obstacles to healthcare access, such as a lack of investment, clinical resources, and hospital infrastructure. Fund III aims to support founders building technology-led businesses that improve healthcare access, affordability and quality while addressing these gaps.
HealthQuad stated that healthcare is entering a period of rapid transformation driven by artificial intelligence, digital adoption and changing patient needs. The firm sees strong opportunities in preventive care, continuous patient monitoring and technology-enabled healthcare services.
According to the company, its sector-focused investment strategy is strengthened by access to Quadria Group’s healthcare ecosystem, which provides portfolio companies with strategic partnerships, growth opportunities and support for expansion into global markets.
